Major North American hospital to deploy large Ascom Myco solution
Over 500 Ascom Myco smartphones combined with Ascom Unite software to be installed in a digital hospital in North America
A major North American acute care hospital has placed an order to install a large Ascom Myco solution by September 2015. The solution includes over 500 Ascom Myco smartphones combined with Ascom Unite software. This first major implementation in North America exceeds a value of CHF 500'000 in overall revenue for Ascom, and is expected to be the first of many purchases for the healthcare network involved. The 550 beds hospital employs 4'000 people serving their region at three sites with a daily mission of improved patient engagement. The Ascom Myco solution will be utilized within a new 170'000 square meters facility that will be a technological showcase as the region's first fully digital hospital.
The combination of Ascom Myco, the innovative purpose-built smartphone for healthcare, with Ascom Unite software provides the hospital a full solution enabling mobile caregiver's real-time, easy access to patient information anywhere in the facility. Critical lab results, cardiac waveforms, patient monitoring alarms, messages and calls are catalogued, organized and, if need be, automatically escalated. Time saved may then be spent on better patient care.
"We are very proud of this first important Myco order win in North America since it reinforces our position as a leading Healthcare ICT provider. After a few smaller orders, this is now the first large project where Ascom Myco, our Unite software and our integration capabilities have made the difference. We are assured that we can help transform healthcare by providing integrated workflow intelligence, focusing specifically on mission-critical communication and information" says Claes Ödman, General Manager, Ascom Wireless Solutions.
This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).